D-penicillamine prevents the development of hepatitis in Long-Evans Cinnamon rats with abnormal copper metabolism

Hepatology. 1992 Jan;15(1):82-7. doi: 10.1002/hep.1840150116.

Abstract

The Long-Evans Cinnamon rat is a mutant strain that contracts hereditary hepatitis and, eventually, spontaneous hepatocellular carcinoma. Because we found a corresponding gross copper accumulation in the liver of the rats, we examined whether the development of hepatitis in our rat system could be prevented by administration of D-penicillamine. D-Penicillamine is a copper-chelating agent and one of the drugs effective for human Wilson's disease, in which abnormal copper metabolism is also observed. The results show that D-penicillamine treatment inhibited the elevation of serum transaminases, suppressed abnormal histological changes in the liver and completely prevented the onset of hepatitis in the Long-Evans Cinnamon rats. We further found that the copper concentration in the liver and serum copper and ceruloplasmin levels were decreased, whereas the urinary copper level was increased in the D-penicillamine-treated Long-Evans Cinnamon rats. These findings demonstrate that the pathogenesis of hereditary hepatitis in Long-Evans Cinnamon rats is due to abnormal copper accumulation in the liver.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Aspartate Aminotransferases / blood
  • Chelating Agents / pharmacology*
  • Copper / metabolism*
  • Female
  • Hepatitis, Animal / genetics
  • Hepatitis, Animal / prevention & control*
  • Histocytochemistry / methods
  • Male
  • Metabolism, Inborn Errors / blood
  • Metabolism, Inborn Errors / drug therapy*
  • Penicillamine / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Rats, Mutant Strains
  • Staining and Labeling

Substances

  • Chelating Agents
  • Copper
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Penicillamine